Can Troponin Be Elevated in PE?
Yes, troponin is frequently elevated in pulmonary embolism, occurring in 30-60% of patients depending on the assay used, and serves as an important prognostic marker for adverse outcomes including mortality. 1
Prevalence of Troponin Elevation
The frequency of troponin elevation in acute PE varies by assay sensitivity:
- 30% of patients show elevation using conventional troponin assays 1
- 60% of patients demonstrate elevation with high-sensitivity assays 1
- Studies consistently report ranges of 20-70% across different populations 2, 3, 4
Mechanism of Troponin Elevation
The underlying pathophysiology involves right ventricular (RV) myocardial injury resulting from acute pressure overload:
Primary Mechanism: RV Strain and Ischemia
- Acute PE causes sudden elevation in pulmonary vascular resistance
- This creates RV afterload mismatch leading to RV dilation and wall stress
- The dilated, overloaded RV develops subendocardial ischemia due to:
Supporting Evidence
Troponin elevation correlates strongly with:
- RV dysfunction on echocardiography: 62.5% of patients with RV dilation had positive troponin versus only 28.6% with normal RV size (p=0.009) 2
- Greater clot burden: Patients with elevated troponin had significantly more segmental perfusion defects (p=0.0002) 2
- Proximal vessel involvement: 12-fold higher odds of emboli in pulmonary trunk or main arteries 4
Alternative Mechanism (Rare)
In rare cases with patent foramen ovale or atrial septal defect, paradoxical coronary embolism through right-to-left shunting can cause true myocardial infarction 5
Prognostic Significance
Elevated troponin is a powerful predictor of adverse outcomes, with the 2019 ESC Guidelines emphasizing its role in risk stratification 1:
Mortality Risk
- 5.2-fold increased risk of mortality in unselected PE patients (OR 5.2,95% CI 3.3-8.4) 1
- 5.9-fold increased risk in hemodynamically stable patients (OR 5.9,95% CI 2.7-13.0) 1
- Recent meta-analysis confirms 5.42-fold increased in-hospital mortality (OR 5.42,95% CI 4.35-6.83) 6
Other Adverse Outcomes
Troponin elevation predicts:
- Hemodynamic decompensation (OR 3.29,95% CI 2.48-4.39) 6
- ICU admission (OR 5.81,95% CI 3.52-9.68) 6
- Need for reperfusion therapy 4, 7
Clinical Application
Sex-Specific Considerations
Recent evidence suggests sex-specific cutoffs may improve accuracy 7:
- Women: ≥25 pg/mL (high-sensitivity assay)
- Men: ≥50 pg/mL (high-sensitivity assay)
- Women show higher prevalence of elevation (49.1% vs 30.4%) but similar prognostic value
Important Caveats
- Low specificity when used alone: Troponin elevation has relatively low positive predictive value in isolation 1
- High negative predictive value: Normal high-sensitivity troponin effectively rules out high-risk PE 1
- Must be interpreted with clinical and imaging findings: Combine with RV assessment and clinical scores for optimal risk stratification 1, 8
- Prior coronary disease does not alter interpretation: Troponin kinetics and prognostic value remain consistent regardless of underlying CAD 9
Risk Stratification Framework
Per ESC Guidelines, troponin should be integrated with 1:
- Clinical severity scores (PESI, simplified PESI)
- Imaging evidence of RV dysfunction (echo or CT showing RV/LV ratio ≥1.0)
- Other biomarkers (BNP/NT-proBNP) when available
The combination of elevated troponin plus RV dysfunction identifies intermediate-high risk patients who may benefit from closer monitoring or escalated therapy, while normal troponin helps identify truly low-risk patients suitable for outpatient management.